CreativeOne Wealth LLC Has $610,000 Holdings in CVS Health Co. (NYSE:CVS)

CreativeOne Wealth LLC lifted its position in shares of CVS Health Co. (NYSE:CVS) by 34.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,726 shares of the pharmacy operator’s stock after buying an additional 1,961 shares during the quarter. CreativeOne Wealth LLC’s holdings in CVS Health were worth $610,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Atticus Wealth Management LLC lifted its stake in shares of CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares in the last quarter. USA Financial Formulas lifted its stake in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in shares of CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 243 shares in the last quarter. ZRC Wealth Management LLC lifted its stake in shares of CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 400 shares in the last quarter. Finally, Coston McIsaac & Partners lifted its stake in shares of CVS Health by 42.6% in the fourth quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after buying an additional 161 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the topic of a number of recent analyst reports. Royal Bank of Canada dropped their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. Truist Financial reaffirmed a “buy” rating and issued a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Argus lowered their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. Finally, SVB Leerink reaffirmed a “market perform” rating and issued a $60.00 price objective (down previously from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. Nine research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $76.75.

CVS Health Price Performance

CVS stock opened at $57.24 on Thursday. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a one year low of $53.70 and a one year high of $83.25. The stock has a market cap of $71.86 billion, a PE ratio of 10.10, a P/E/G ratio of 0.55 and a beta of 0.56. The firm has a 50 day simple moving average of $67.98 and a two-hundred day simple moving average of $72.13.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The company had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period in the prior year, the firm earned $2.20 EPS. CVS Health’s quarterly revenue was up 3.7% on a year-over-year basis. On average, analysts predict that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.65%. CVS Health’s dividend payout ratio (DPR) is 46.75%.

Insider Activity

In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.24% of the stock is owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.